Diabetes keto acidosis management
I'll start by reading the medical library skill, then search for DKA management content in parallel.
Reading File
Now I'll search the library and PubMed in parallel for DKA management.
Finding Sources
Searching PubMed
"diabetic ketoacidosis"[MeSH Terms] AND management
Now read the most relevant DKA sections from Rosen's Emergency Medicine and Goldman-Cecil in parallel.
Reading File
Reading File
Let me read more of the Rosen's Emergency Medicine DKA management section and the Goldman-Cecil treatment section in parallel.
Reading File
Reading File
Excellent content retrieved. I now have comprehensive DKA management detail from both Rosen's and Goldman-Cecil. Let me compile a thorough, well-structured answer.
Diabetic Ketoacidosis (DKA) - Management
Diagnostic Criteria
The three hallmarks of DKA are (Goldman-Cecil Medicine):
- Hyperglycemia: blood glucose typically >250 mg/dL (though euglycemic DKA at ≤300 mg/dL occurs in up to 18% of cases, especially with SGLT2 inhibitors)
- Ketosis: urinary ketones 2+ or serum ketones ≥3.0 mmol/L
- Acidosis: arterial/venous pH <7.3 and serum bicarbonate <18 mmol/L
| Severity | pH | HCO3 | Mental Status |
|---|---|---|---|
| Mild | 7.25-7.30 | 15-18 | Alert |
| Moderate | 7.00-7.24 | 10-14 | Alert/drowsy |
| Severe | <7.00 | <10 | Stupor/coma |
Precipitating Factors
- Infection (most common)
- Inadequate insulin/non-adherence
- New-onset diabetes
- Acute coronary syndrome
- Drugs: corticosteroids, SGLT2 inhibitors, clozapine, olanzapine, cocaine, sympathomimetics, thiazides
- Endocrinopathies: Cushing syndrome, thyrotoxicosis, acromegaly
- Cerebrovascular accident, acute PE, acute pancreatitis
Pathophysiology (Brief)
Insulin deficiency + counter-regulatory hormone excess (glucagon, cortisol, epinephrine) drives:
- Hepatic glucose overproduction (glycogenolysis + gluconeogenesis)
- Lipolysis → free fatty acids → ketone bodies (beta-hydroxybutyrate, acetoacetate, acetone) in the liver
- Osmotic diuresis → dehydration and electrolyte loss (Na, K, Mg, Phosphate)
Average fluid/electrolyte deficits in severe DKA (Rosen's Emergency Medicine):
| Electrolyte | Deficit |
|---|---|
| Water | 70-120 mL/kg |
| Sodium | 8-10 mEq/kg |
| Potassium | 5-7 mEq/kg |
| Chloride | 6-8 mEq/kg |
| Phosphorus | ~3 mEq/kg |
Management: The 4 Pillars
1. Fluid Resuscitation
- First hour: 1-1.5 L of isotonic saline (0.9% NaCl) IV to restore circulating volume
- Subsequent hours: Switch to 0.45% NaCl at 250-500 mL/hr once volume is partially restored, or continue 0.9% NaCl depending on corrected sodium
- Add dextrose (D5 or D10) when blood glucose falls to 200-250 mg/dL to allow continued insulin infusion without causing hypoglycemia
Corrected sodium: For every 100 mg/dL of glucose above normal, add 1.6 mEq/L to the measured sodium to get the true value.
2. Insulin
- Do NOT start insulin if K+ <3.5 mEq/L - replace potassium first to prevent fatal hypokalemia
- Standard regimen: Regular insulin IV infusion at 0.1 units/kg/hr (or bolus 0.1 units/kg then 0.05 units/kg/hr)
- Target: blood glucose fall of 50-75 mg/dL per hour
- When glucose reaches ~200-250 mg/dL: reduce insulin rate to 0.02-0.05 units/kg/hr AND add dextrose to fluids - keep running insulin until anion gap closes
- Do NOT stop insulin just because glucose is normal - continue until ketoacidosis resolves (pH >7.3, bicarbonate >15, anion gap normal)
Subcutaneous insulin: A 2024 systematic review (Alnuaimi et al., PMID 39090718) and a 2026 meta-analysis of RCTs (Thammakosol et al., PMID 41208563) suggest subcutaneous insulin protocols may be comparable to IV infusion in mild-moderate DKA and that early addition of subcutaneous basal insulin reduces rebound hyperglycemia.
3. Potassium Replacement (Critical)
Serum K+ appears falsely normal or high in DKA due to acidosis shifting K+ out of cells. Total body deficit is always present.
| Serum K+ | Action |
|---|---|
| <3.5 mEq/L | Hold insulin; give 40 mEq/hr IV KCl until K+ ≥3.5, then start insulin |
| 3.5-5.0 mEq/L | Give 20-40 mEq/hr IV KCl with insulin |
| >5.0 mEq/L | Hold K+; recheck every 2 hours |
Corrected K+ for pH: Subtract 0.6 mEq/L for every 0.1-unit pH decrease below 7.4. (e.g., K+ = 5 mEq/L at pH 6.94 → true K+ ≈ 2 mEq/L - severe hypokalemia)
4. Identify and Treat the Precipitant
- Cultures (blood, urine) if infection suspected
- ECG (rule out MI as precipitant; monitor for K+ changes)
- Consider cardiac biomarkers, lipase (pancreatitis), head CT (CVA) as clinically indicated
Bicarbonate - When to Use?
Generally NOT recommended for most DKA. Routine bicarbonate can worsen hypokalemia, cause paradoxical CNS acidosis, and delay ketone clearance.
- Consider only if pH <7.0 or bicarbonate <5 mmol/L with hemodynamic compromise
- If used: 100 mEq NaHCO3 in 400 mL sterile water + 20 mEq KCl over 2 hours
Phosphate Replacement
- Routine replacement is NOT recommended
- Consider if serum phosphate <1 mg/dL, or in patients with cardiac dysfunction, hemolytic anemia, or respiratory depression
- Give potassium phosphate 20-30 mEq over 2 hours if indicated
Monitoring During Treatment
| Parameter | Frequency |
|---|---|
| Blood glucose | Every 1 hour |
| Basic metabolic panel (K+, Na+, BUN, Cr) | Every 2-4 hours |
| Anion gap | Every 2-4 hours |
| ABG/VBG | Every 2-4 hours initially |
| Urine output | Hourly |
Resolution criteria (DKA cleared when ALL of the following are met):
- Blood glucose <200 mg/dL
- Serum bicarbonate ≥15 mEq/L
- Venous pH >7.3
- Anion gap ≤12
Transition to Subcutaneous Insulin
- Give the first dose of long-acting subcutaneous insulin 2-4 hours before stopping IV insulin to prevent rebound hyperglycemia
- Overlap is mandatory - do NOT abruptly stop IV insulin
- For known diabetics: resume their prior insulin regimen
- For new-onset T1DM: initiate a basal-bolus regimen
Special Considerations
Euglycemic DKA (SGLT2 inhibitor-associated)
- Blood glucose can be normal or only mildly elevated
- Maintain high suspicion in patients on empagliflozin, dapagliflozin, canagliflozin
- Treat with same insulin/fluid protocol; STOP the SGLT2 inhibitor
Pregnancy
- DKA occurs at lower glucose levels in pregnancy (~200 mg/dL)
- Fetal mortality is significant (~9-35% in older reports)
- A 2025 systematic review (Cozzi-Glaser et al., PMID 40447103) confirms adverse pregnancy outcomes; aggressive treatment and fetal monitoring are mandatory
Cerebral Edema (mainly pediatric)
- Most feared complication of DKA treatment
- Risk increased with rapid fluid replacement, marked hypocapnia, bicarbonate use
- Suspect if headache, deteriorating consciousness, or pupillary changes develop during treatment
- Treat with mannitol 0.5-1 g/kg IV or 3% hypertonic saline
Key Pitfalls to Avoid
- Starting insulin before correcting K+ <3.5 - can cause fatal arrhythmia
- Stopping insulin once glucose normalizes - DKA may still be active
- Rapid fluid replacement in children - cerebral edema risk
- Missing euglycemic DKA in SGLT2 inhibitor users
- Misinterpreting leukocytosis as infection - it reflects ketosis severity
- Misinterpreting falsely elevated creatinine and amylase in DKA
Sources: Rosen's Emergency Medicine: Concepts and Clinical Practice (9780323757898); Goldman-Cecil Medicine International Edition (9780323930345)
This is a shared conversation. Sign in to Orris to start your own chat.